Terms: = Ovarian cancer AND EIF4A2, DDX2B, 1974, ENSG00000156976, EIF4F, BM-010, EIF4A AND Prognosis
13 results:
1. Primary extra-uterine and extra-ovarian mullerian adenosarcoma: case report and literature review.
Mandato VD; Torricelli F; Mastrofilippo V; Valli R; Aguzzoli L; La Sala GB
BMC Cancer; 2018 Feb; 18(1):134. PubMed ID: 29402239
[TBL] [Abstract] [Full Text] [Related]
2. The Impact of Underweight Status on the prognosis of ovarian cancer Patients: A Meta-Analysis.
Pergialiotis V; Doumouchtsis SK; Perrea D; Vlachos GD
Nutr Cancer; 2016; 68(6):918-25. PubMed ID: 27351098
[TBL] [Abstract] [Full Text] [Related]
3. prognosis of ovarian clear cell carcinoma compared to other histological subtypes: a meta-analysis.
Lee YY; Kim TJ; Kim MJ; Kim HJ; Song T; Kim MK; Choi CH; Lee JW; Bae DS; Kim BG
Gynecol Oncol; 2011 Sep; 122(3):541-7. PubMed ID: 21640372
[TBL] [Abstract] [Full Text] [Related]
4. Predictors of recurrence of ovarian granulosa cell tumors.
Nosov V; Silva I; Tavassoli F; Adamyan L; Farias-Eisner R; Schwartz PE
Int J Gynecol Cancer; 2009 May; 19(4):628-33. PubMed ID: 19509561
[TBL] [Abstract] [Full Text] [Related]
5. Malignant mixed mesodermal ovarian tumor treatment and prognosis: a 20-year experience.
Le T; Krepart GV; Lotocki RJ; Heywood MS
Gynecol Oncol; 1997 May; 65(2):237-40. PubMed ID: 9159331
[TBL] [Abstract] [Full Text] [Related]
6. Epidemiologic pathology of ovarian cancer from the Vaud cancer Registry, Switzerland.
Levi F; Franceschi S; La Vecchia C; Ruzicka J; Gloor E; Randimbison L
Ann Oncol; 1993 Apr; 4(4):289-94. PubMed ID: 8518218
[TBL] [Abstract] [Full Text] [Related]
7. The prognostic importance of myelosuppression in the response to chemotherapy and survival in advanced ovarian carcinoma.
Sorbe B; Helsing M
Cancer; 1987 Feb; 59(4):690-4. PubMed ID: 3802028
[TBL] [Abstract] [Full Text] [Related]
8. ovarian carcinoma. The significance of restaging laparotomies with negative outcomes.
Potkul RK; Delgado G; Petrilli ES; Yageric A
Arch Surg; 1986 Nov; 121(11):1262-4. PubMed ID: 3778198
[TBL] [Abstract] [Full Text] [Related]
9. [Effects of chemotherapy of advanced malignant ovarian tumors].
Ohta M; Sakakibara K; Casanova H; Nishida Y; Kano T; Tomoda Y; Kazato S; Miyazaki T; Arii Y; Umemura S
Gan To Kagaku Ryoho; 1985 Nov; 12(11):2208-15. PubMed ID: 4062320
[TBL] [Abstract] [Full Text] [Related]
10. [Pseudomyxoma peritonei. Two illustrative cases].
Pamich G; Giurissa A
Arch Sci Med (Torino); 1983; 140(3):307-16. PubMed ID: 6675589
[TBL] [Abstract] [Full Text] [Related]
11. Proliferative serous tumors of the ovary. Histologic features and prognosis.
Katzenstein AL; Mazur MT; Morgan TE; Kao MS
Am J Surg Pathol; 1978 Dec; 2(4):339-55. PubMed ID: 736209
[TBL] [Abstract] [Full Text] [Related]
12. Granulosa cell tumors. A clinical review of 61 cases.
Pankratz E; Boyes DA; White GW; Galliford BW; Fairey RN; Benedet JL
Obstet Gynecol; 1978 Dec; 52(6):718-23. PubMed ID: 733139
[TBL] [Abstract] [Full Text] [Related]
13. Gonadal and extragonadal yolk sac carcinomas: a clinicopathologic study of 14 cases.
Roth LM; Panganiban WG
Cancer; 1976 Feb; 37(2):812-20. PubMed ID: 56218
[TBL] [Abstract] [Full Text] [Related]
